![Vincent Sandanayaka](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenienza dei contatti di primo grado di Vincent Sandanayaka
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Nirogy Therapeutics, Inc.
![]() Nirogy Therapeutics, Inc. BiotechnologyHealth Technology Nirogy Therapeutics, Inc. is an American biotechnology company that operates in the healthcare industry. The company is based in N/A. The company was founded in 2014 by Vincent Sandanayaka, Jaime Escobedo. Simon C. Pedder has been the CEO of the company since 2022.
6
| Holding Company | Biotechnology | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Vincent Sandanayaka tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ONCOTELIC THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
ONCOLOGY PHARMA INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
DELCATH SYSTEMS, INC. | Medical Specialties | Director/Board Member | |
Novartis Oncology, Inc.
![]() Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ATHENEXPAR | Pharmaceuticals: Major | Corporate Officer/Principal | |
CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Biotechnology | Founder | |
FORMA Therapeutics, Inc.
![]() FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Biotechnology | Corporate Officer/Principal | |
Lyric Pharmaceuticals, Inc.
![]() Lyric Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Lyric Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company. The firm develops novel gastrointestinal therapeutics for unmet medical needs in the hospital settings. The company was founded by David Wurtman and M. Scott Harris in 2013 and is headquartered in South San Fancisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
Stanford University | College/University | Graduate Degree | |
Hoffmann-La Roche, Inc.
![]() Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Shearwater Corp.
![]() Shearwater Corp. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Shearwater Corp. is a company that provides research services focused on health care applications of advanced PEGylation. The company is based in Huntsville, AL. The company was founded by James R. Hudson, J. Milton Harris. Shearwater was acquired by Nektar Therapeutics on July 02, 2001 for $164.50 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Chrysalis BioTherapeutics, Inc.
![]() Chrysalis BioTherapeutics, Inc. Pharmaceuticals: OtherHealth Technology Part of Capstone Therapeutics Corp., Chrysalis BioTherapeutics, Inc. develops therapeutics to accelerate the healing of hard and soft tissue. The company is based in Galveston, TX. The company was founded by Dennis L. McWilliams. Chrysalis BioTherapeutics was acquired by Capstone Therapeutics Corp. on August 06, 2004 for $34.50 million. | Pharmaceuticals: Other | Founder | |
Concordia University | College/University | Graduate Degree | |
The University of Texas at Austin | College/University | Undergraduate Degree Undergraduate Degree | |
The University of Waterloo | College/University | Undergraduate Degree | |
PTV Sciences LP
![]() PTV Sciences LP Investment ManagersFinance PTV Sciences LP (PTV Healthcare Capital) is a venture capital firm founded in 2003 by Matthew S. Crawford and Evan S. Melrose. The firm is headquartered in Houston, Texas. | Investment Managers | Private Equity Investor | |
The Ex-Students' Association
![]() The Ex-Students' Association Miscellaneous Commercial ServicesCommercial Services The Ex-Students' Association operates as an alumni association. The non-profit company is based in Austin, TX. | Miscellaneous Commercial Services | Director/Board Member | |
Universidad Católica del Norte | College/University | Undergraduate Degree | |
Weizmann Institute of Science | College/University | Director/Board Member | |
Texas Life Science Center for Innovation & Commercialization | Director/Board Member | ||
SHVMS, LLC
![]() SHVMS, LLC Investment ManagersFinance SHVMS, LLC (Sante Ventures) is a Venture Capital firm founded in 2006 by Joe Hal Cunningham, Kevin Myles Lalande and Doug Dewitt French. The firm is headquartered in Austin, Texas. | Investment Managers | Private Equity Investor Private Equity Investor | |
Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
The University of Texas Southwestern Medical Center | College/University | Doctorate Degree | |
Columbia Law School | College/University | Graduate Degree | |
AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
IMMUNEERING CORPORATION | Pharmaceuticals: Major | Director/Board Member | |
CELLECTAR BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Eboo Pharmaceuticals, Inc. | Director/Board Member | ||
University of Saskatchewan College of Medicine | College/University | Doctorate Degree | |
Ballantyne Therapeutics, Inc.
![]() Ballantyne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Ballantyne Therapeutics, Inc. manufactures pharmaceuticals. The private company is based in Charlotte, NC. | Pharmaceuticals: Major | Director/Board Member | |
Atlantic Research Group, Inc.
![]() Atlantic Research Group, Inc. Miscellaneous Commercial ServicesCommercial Services Atlantic Research Group, Inc. operates as a rare disease-focused contract research organization that provides comprehensive clinical program development services ranging from pre-launch consulting to commercialization. It offers strategic consulting, clinical trial management services, clinic data and analytics solutions, pharmacovigilance and medical monitoring. The company was founded by Paul Bishop and Lyle Camblos in 2004 and is headquartered in Charlottesville, VA. | Miscellaneous Commercial Services | Director/Board Member | |
BoxCar Partners LLC | Founder | ||
APOLLO ENDOSURGERY, INC. | Medical Specialties | Founder | |
Apollo Endosurgery UK Ltd.
![]() Apollo Endosurgery UK Ltd. Medical DistributorsDistribution Services Founded in 2014, Apollo Endosurgery UK Ltd. is a company that wholesales surgical goods. Part of Boston Scientific Corp., the company is based in London, UK. | Medical Distributors | Director/Board Member | |
Surgical Safety Technologies, Inc.
![]() Surgical Safety Technologies, Inc. Information Technology ServicesTechnology Services Surgical Safety Technologies, Inc. improves surgical performance and safety while reducing healthcare costs. The company is based in Toronto, Canada. The Canadian company was founded by Teodor Grantcharov. | Information Technology Services | Director/Board Member | |
KelaHealth, Inc.
![]() KelaHealth, Inc. Packaged SoftwareTechnology Services kelaHealth, Inc. engages in the provision of software platform that combines predictive algorithms to reduce surgical complications. The company is headquartered in Durham, NC. | Packaged Software | Director/Board Member | |
Glyscend, Inc.
![]() Glyscend, Inc. Pharmaceuticals: MajorHealth Technology Glyscend, Inc. engages in the development of therapeutics for treating metabolic diseases. It focuses on providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. The company was founded by Kevin Colbert in September 2014 and is headquartered in Baltimore, MD. | Pharmaceuticals: Major | Chairman | |
Asylia Therapeutics, Inc.
![]() Asylia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Asylia Therapeutics, Inc. is a private biotechnology company founded in 2019 by Richard Jones, Robert Z. Orlowski, and Ronald A. DePinho. The company is based in Houston, TX. Asylia Therapeutics is focused on developing novel immune modulating therapies for cancer and autoimmune diseases. The company's drug pipeline is capable of modulating antigen presentation to the immune system, which has produced anti-tumor responses across multiple cancer models. The company is supported by a $3 million grant from the Cancer Prevention & Research Institute of Texas. The CEO is Karthik Radhakrishnan. | Pharmaceuticals: Major | President Director/Board Member | |
Sporos Bioventures, Inc.
![]() Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | Medical/Nursing Services | Chief Executive Officer Founder | |
Sparkmed Advisors LLC | Private Equity Investor | ||
Carmine Therapeutics, Inc. | Director/Board Member | ||
RapidPulse, Inc.
![]() RapidPulse, Inc. Electronic Equipment/InstrumentsElectronic Technology RapidPulse, Inc. is a medical device company that specializes in developing minimally invasive vascular products for ischemic stroke. The company is based in Miami, FL. The company is focused on advancing the development of the RapidPulse™ cyclic aspiration system, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinout of Syntheon LLC, a medical device incubator dedicated to developing innovative products in the medical device industry. The CEO of the company is Sean McBrayer. | Electronic Equipment/Instruments | Director/Board Member | |
BeeKeeperAI, Inc.
![]() BeeKeeperAI, Inc. Packaged SoftwareTechnology Services BeeKeeperAI, Inc. is an American company that accelerates healthcare AI through a secure collaboration platform for algorithm owners and data stewards. The company's approach is to remove the barriers to data rather than relying on de-identified or synthetic data solutions. The company was founded by Michael Blum, Rachael Callcut, Mary Elizabeth Chalk, and Bob Rogers, with Michael Blum serving as the CEO since incorporation. | Packaged Software | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 44 |
Canada | 5 |
Cile | 2 |
Israele | 2 |
Regno Unito | 2 |
Settori
Health Technology | 25 |
Consumer Services | 11 |
Finance | 4 |
Technology Services | 4 |
Commercial Services | 3 |
Posizioni
Director/Board Member | 35 |
Corporate Officer/Principal | 13 |
President | 9 |
Chief Executive Officer | 8 |
Founder | 8 |
Contatti più connessi
Insiders | |
---|---|
Simon Pedder | 19 |
Elan Ezickson | 17 |
Dennis McWilliams | 17 |
Casey Cunningham | 8 |
Joseph Kekst | 7 |
Jaime Escobedo | 5 |
- Borsa valori
- Insiders
- Vincent Sandanayaka
- Connessioni Società